Compounds > busulfan
Page last updated: 2024-10-24

busulfan and Bone Marrow Diseases

busulfan has been researched along with Bone Marrow Diseases in 46 studies

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research Excerpts

ExcerptRelevanceReference
"Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis."7.65Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. ( Kim, HC; Lindenbaum, J; Pezzimenti, JF, 1976)
"Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis."3.65Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. ( Kim, HC; Lindenbaum, J; Pezzimenti, JF, 1976)
"The risk of major thrombosis is higher in ET patients aged more than 60 ys."2.39Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers. ( Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ, 1996)

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-199034 (73.91)18.7374
1990's7 (15.22)18.2507
2000's4 (8.70)29.6817
2010's1 (2.17)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneidawind, D1
Federmann, B1
Buechele, C1
Helwig, A1
Schmohl, J1
Vogel, W1
Faul, C1
Kanz, L1
Bethge, WA1
DAMESHEK, W1
GRANVILLE, NB1
RUBIO, F1
PAOLINO, W1
BACHI, C1
de OLIVEIRA, H1
CRUZ, E1
de FONSECA, AS1
MEDEIROS, M1
BRODY, JI1
MCKENZIE, D1
KIMBALL, SG1
THOMAS, JR1
Chen, J1
Lokeshwar, N1
Kumar, L1
Kumari, M1
Sauer, M1
Zeidler, C1
Meissner, B1
Rehe, K1
Hanke, A1
Welte, K1
Lohse, P1
Sykora, KW1
Molyneux, G1
Gibson, FM1
Whayman, M1
Turton, JA1
Larizza, P1
Lohrmann, HP1
Parkman, R1
Rappeport, JM1
Hellman, S1
Lipton, J1
Smith, B1
Geha, R1
Nathan, DG1
Ideriha, NM1
Vugman, I1
Falcão, RP1
Labedzki, L1
Noack, D1
Schiller, G1
Vescio, R1
Freytes, C1
Spitzer, G1
Sahebi, F1
Lee, M1
Wu, CH1
Cao, J1
Lee, JC1
Hong, CH1
Scheid, C1
Pettengell, R1
Ghielmini, M1
Radford, JA1
Morgenstern, GR1
Stern, PL1
Crowther, D1
Shepherd, PC1
Richards, S1
Allan, NC1
Xue, Y1
Zhou, XJ1
Yu, F1
Gu, J1
Guo, Y1
Xie, X1
Lin, B1
Barbui, T1
Finazzi, G1
Dupuy, E1
Kiladjian, JJ1
Brière, J1
Morley, A1
Trainor, K1
Blake, J1
Demidova, AV1
Siver, AP1
Pogorzhel'skiĭ, VI1
Trainor, KJ1
Morley, AA1
Pezzimenti, JF1
Kim, HC1
Lindenbaum, J1
Schäfer, R1
Schneider, HM1
Hill, K1
Berger, DP1
Winterhalter, BR1
Dengler, WA1
Fiebig, HH1
Fiedler, W1
Goetz, G1
Weh, HJ1
Hossfeld, DK1
Möller, H1
Waldenström, J1
Finney, R1
McDonald, GA1
Baikie, AG1
Douglas, AS1
Ganda, OP1
Mangalik, A1
Nagel, GA1
Galton, DA2
Wasserman, LR1
Marcolongo, R1
Di Paolo, N1
Bianco, G1
Bravi, A1
Pegrum, GD1
Dougan, L1
Onesti, P1
Woodliff, HJ1
Brandt, L1
Weatherall, DJ1
Kay, HE1
Gibson, OM1
Burgess, MA1
Stanley, LG1
Winkelman, J1
Fisher, H1
Melnyk, J1
Wilson, JF1
Johnson, RE1
Mauruce, PA1
Ferrier, S1
Alberto, P1
Freund, M1
Dunjic, A1
Cuvelier, AM1
Jovanovic, D1
Linchet, G1
Vodopick, H1
Hamilton, HE1
Jackson, HL1
Peng, CT1
Sheets, RF1
Hunstein, W1
Svetlichnyĭ, IS1
Kovalenko, VL1

Reviews

6 reviews available for busulfan and Bone Marrow Diseases

ArticleYear
Animal models for acquired bone marrow failure syndromes.
    Clinical medicine & research, 2005, Volume: 3, Issue:2

    Topics: Anemia, Aplastic; Animals; Benzene; Bone Marrow Diseases; Busulfan; Chloramphenicol; Disease Models,

2005
The problem of permanent bone marrow damage after cytotoxic drug treatment.
    Oncology, 1984, Volume: 41, Issue:3

    Topics: Animals; Antineoplastic Agents; Bone Marrow Diseases; Busulfan; Carmustine; Cell Division; Cell Surv

1984
[Hematopoietic stimulation for enhanced bone marrow regeneration after chemotherapy (author's transl)].
    Klinische Wochenschrift, 1980, Mar-03, Volume: 58, Issue:5

    Topics: Anabolic Agents; Animals; Blood Transfusion; Bone Marrow; Bone Marrow Diseases; Busulfan; Corynebact

1980
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Adult; Aged; Alkylating Agents; Anemia, Megaloblastic; Arrhythmias, Cardiac; Bone Marrow Diseases; B

1996
Chemotherapy of chronic myelocytic leukemia.
    Seminars in hematology, 1969, Volume: 6, Issue:4

    Topics: Blood Cell Count; Bone Marrow Diseases; Busulfan; Female; Humans; Hydroxyurea; Leukemia, Myeloid; Le

1969
The management of polycythaemia vera.
    British journal of haematology, 1971, Volume: 21, Issue:4

    Topics: Acute Disease; Alkylating Agents; Bloodletting; Bone Marrow Diseases; Busulfan; Humans; Leukemia; Ph

1971

Trials

2 trials available for busulfan and Bone Marrow Diseases

ArticleYear
Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
    Bone marrow transplantation, 2007, Volume: 39, Issue:3

    Topics: Abnormalities, Multiple; Adolescent; Bone Marrow Diseases; Busulfan; Child; Child, Preschool; Cyclop

2007
Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.
    Blood, 1995, Jul-01, Volume: 86, Issue:1

    Topics: Actuarial Analysis; Adrenal Cortex Hormones; Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplast

1995

Other Studies

38 other studies available for busulfan and Bone Marrow Diseases

ArticleYear
Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.
    Annals of hematology, 2016, Volume: 95, Issue:1

    Topics: Adult; Aged; Bone Marrow Diseases; Busulfan; Female; Follow-Up Studies; Hematopoietic Stem Cell Tran

2016
Therapy of the myeloproliferative disorders with myleran.
    Annals of the New York Academy of Sciences, 1958, Apr-24, Volume: 68, Issue:3

    Topics: Bone Marrow; Bone Marrow Diseases; Busulfan; Myeloproliferative Disorders

1958
[Total bone marrow aplasia caused by uncontrolled treatment with dimethanesulfonoxybutane in a case of chronic myelocytic leukemia].
    Minerva medica, 1960, Oct-14, Volume: 51

    Topics: Bone Marrow; Bone Marrow Diseases; Busulfan; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-A

1960
Accidental ingestion of a toxic dose of myleran by a child.
    Acta haematologica, 1963, Volume: 29

    Topics: Alopecia; Bone Marrow Diseases; Busulfan; Child; Humans; Mouth

1963
MYLERAN AS A THERAPEUTIC ADJUNCT IN GASTROINTESTINAL BLEEDING COMPLICATING MYELOPROLIFERATIVE DISORDERS.
    Gastroenterology, 1963, Volume: 45

    Topics: Anemia; Anemia, Hypochromic; Blood Platelet Disorders; Bone Marrow Diseases; Busulfan; Gastrointesti

1963
EOSINOPHILIC LEUKEMIA PRESENTING WITH ERYTHROCYTOSIS.
    Blood, 1963, Volume: 22

    Topics: Black People; Bone Marrow Diseases; Busulfan; Eosinophilia; Erythrocytes; Humans; Hypereosinophilic

1963
Severe bone marrow aplasia following imatinib mesylate in a patient with chronic myelogenous leukemia.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:5

    Topics: Antineoplastic Agents; Benzamides; Bone Marrow Diseases; Busulfan; Fatal Outcome; Female; Humans; Im

2005
Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse.
    International journal of experimental pathology, 2008, Volume: 89, Issue:2

    Topics: Animals; Antineoplastic Agents, Alkylating; Blood Cell Count; Body Weight; Bone Marrow Cells; Bone M

2008
[Introduction and general data on the subject of the pathology of drugs].
    Minerva medica, 1984, Aug-25, Volume: 75, Issue:32-33

    Topics: Agranulocytosis; Anemia, Hemolytic; Anemia, Megaloblastic; Anemia, Sideroblastic; Bleomycin; Bone Ma

1984
Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation.
    Blood, 1984, Volume: 64, Issue:4

    Topics: Adolescent; Bone Marrow Diseases; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Fe

1984
Ectopic bone marrow development in experimental busulfan-induced hypoplastic anemia in mice.
    Blut, 1984, Volume: 48, Issue:5

    Topics: Anemia, Aplastic; Animals; Blood Cell Count; Bone Development; Bone Marrow; Bone Marrow Diseases; Bo

1984
Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases;

1995
Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
    British journal of haematology, 1994, Volume: 86, Issue:1

    Topics: Adult; Aged; Bone Marrow Diseases; Busulfan; Combined Modality Therapy; Female; Humans; Hydroxyurea;

1994
Karyotype conversion in two patients with chronic myeloid leukaemia after busulphan-induced marrow hypoplasia.
    British journal of haematology, 1996, Volume: 92, Issue:4

    Topics: Adult; Antineoplastic Agents, Alkylating; Base Sequence; Blotting, Southern; Bone Marrow Diseases; B

1996
A primary stem cell lesion in experimental chronic hypoplastic marrow failure.
    Blood, 1975, Volume: 45, Issue:5

    Topics: Animals; Bone Marrow Diseases; Busulfan; Cell Count; Cell Differentiation; Cell Division; Cells, Cul

1975
[Case of myelosan-induced hematopoietic aplasia in erythremia].
    Terapevticheskii arkhiv, 1977, Volume: 49, Issue:2

    Topics: Aged; Bone Marrow Diseases; Busulfan; Female; Humans; Polycythemia Vera

1977
Screening of cytotoxic drugs for residual bone marrow damage.
    Journal of the National Cancer Institute, 1976, Volume: 57, Issue:6

    Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Busulfan; Carmustine; Cell Surviv

1976
Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera.
    Cancer, 1976, Volume: 38, Issue:6

    Topics: Adult; Bone Marrow; Bone Marrow Diseases; Busulfan; Female; Humans; Leukemia, Erythroblastic, Acute;

1976
[Proceedings: Histological and biopsy bone-marrow findings in treated and untreated myeloses].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1975, Volume: 59

    Topics: Biopsy; Bone Marrow Diseases; Bone Marrow Examination; Busulfan; Humans

1975
Preclinical activity of hepsulfam and busulfan in solid human tumor xenografts and human bone marrow.
    Anti-cancer drugs, 1992, Volume: 3, Issue:5

    Topics: Animals; Antineoplastic Agents; Bone Marrow Diseases; Busulfan; Drug Screening Assays, Antitumor; Fe

1992
GM-CSF in busulfan overdosage.
    European journal of haematology, 1990, Volume: 45, Issue:3

    Topics: Anemia; Bone Marrow Diseases; Busulfan; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hu

1990
Letter: Bone marrow damage during treatment of psoriasis with busulphan.
    Acta dermato-venereologica, 1973, Volume: 53, Issue:6

    Topics: Acute Disease; Aged; Autopsy; Blood Platelet Disorders; Bone Marrow Diseases; Busulfan; Hematoma; Hu

1973
Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    British journal of haematology, 1972, Volume: 23, Issue:3

    Topics: Aged; Alkaline Phosphatase; Blood Cell Count; Blood Platelets; Bone Marrow Diseases; Busulfan; Chrom

1972
Delayed toxic effect of busulfan on the marrow.
    The Journal of the Association of Physicians of India, 1973, Volume: 21, Issue:6

    Topics: Adult; Bone Marrow Diseases; Busulfan; Female; Humans; Leukemia, Myeloid; Leukopenia; Male; Middle A

1973
[Complications in oncologic therapy].
    Deutsche medizinische Wochenschrift (1946), 1974, Volume: 99, Issue:18

    Topics: Acute Kidney Injury; Antineoplastic Agents; Bone Marrow Diseases; Busulfan; Cyclophosphamide; Humans

1974
[Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy].
    Haematologica, 1969, Volume: 54, Issue:9

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Examination

1969
Stimulation in vitro of cells from patients with myeloproliferative disorders.
    Blut, 1967, Volume: 14, Issue:5

    Topics: Autoradiography; Bone Marrow Diseases; Busulfan; Culture Techniques; Humans; Lectins; Leukemia, Myel

1967
Cytogenetic studies in chronic granulocytic leukaemia.
    Australasian annals of medicine, 1967, Volume: 16, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aged; Bone Marrow Diseases; Busulfan; Chromosome Aberrations; Chromo

1967
Studies on the phagocytic activity of neutrophilic leukocytes.
    Scandinavian journal of haematology. Supplementum, 1967, Volume: 2

    Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Anemia, Macrocytic; Animals; Biopsy; Bone Marrow Dis

1967
Busulphan and bone marrow depression.
    British medical journal, 1969, Mar-08, Volume: 1, Issue:5644

    Topics: Adult; Aged; Bone Marrow Diseases; Busulfan; Female; Humans; Leukemia, Myeloid; Leukocyte Count; Mal

1969
Cytogenetic remission in acute transformation of chronic granulocytic leukaemia.
    British medical journal, 1969, May-31, Volume: 2, Issue:5656

    Topics: Acute Disease; Aged; Aneuploidy; Bone Marrow Diseases; Busulfan; Cell Transformation, Neoplastic; Ch

1969
Testing for Ph 1 chromosome on mailed specimens of peripheral blood.
    Vox sanguinis, 1971, Volume: 20, Issue:4

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Blood Specimen Collection; Bo

1971
Splenic irradiation following chemotherapy in chronic myelogenous leukemia.
    Radiology, 1971, Volume: 101, Issue:3

    Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Platelets; Bone Marrow Diseases; Busulfan; Child; C

1971
[Chronic myelocytic leukemia: apparent "recovery" for over nine years, following therapeutic medullary hypoplasia. A clinical and cytogenetic study].
    Schweizerische medizinische Wochenschrift, 1971, Dec-11, Volume: 101, Issue:49

    Topics: Adult; Alkaline Phosphatase; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Busulfan; Cytogenet

1971
[The effects of ionizing radiations and radiomimetic drugs on rat bone-marrow cells].
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1971, Volume: 20, Issue:3

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Busulfan; Cell Survival; Cyclophospha

1971
Metabolic fate of tritiated busulfan in man.
    The Journal of laboratory and clinical medicine, 1969, Volume: 73, Issue:2

    Topics: Bone Marrow Diseases; Busulfan; Humans; Leukemia, Lymphoid; Lung Neoplasms; Metabolic Clearance Rate

1969
[Is Myleran (busulfan) a leukemogenic substance?].
    Schweizerische medizinische Wochenschrift, 1965, Oct-23, Volume: 95, Issue:43

    Topics: Anemia, Aplastic; Animals; Bone Marrow Diseases; Busulfan; Leukemia, Experimental; Rats

1965
[On the problem of complications in Myelosan therapy].
    Sovetskaia meditsina, 1966, Volume: 29, Issue:8

    Topics: Adult; Bone Marrow Diseases; Busulfan; Chemical and Drug Induced Liver Injury; Hematologic Diseases;

1966